We participated in BIO Partnering at JPM etc
Over the last two months, we p …
KORTUC is to attend BIO CEO & Investor Conference in February
KORTUC will participate in BIO …
KORTUC Inc. closed financing from SBI Investment to accelerate Pivotal Phase II study in UK and US
Today KORTUC Inc. (KORTUC) ann …
KORTUC Inc. started research collaboration with Okayama University on the tumor immunity by a novel radiosensitizer
KORTUC Inc. announced today th …
KORTUC is featured in the leading story in “Science Japan”
KORTUC is featured in the lead …
KORTUC’s basic research result of tumor reoxygenation was presented at ESTRO 2021
The result of a basic research …
KORTUC Inc. closed financing from AXA Japan to accelerate Pivotal Phase II study of novel radiosensitizer for cancer radiotherapy
Businesswire Today KORTUC Inc. …
Rationale and outcome in various cancer types in clinical practices in Japan were presented at ENA
At ENA 2020 (32nd EORTC-NCI-AA …